These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31400073)

  • 1. Genetic Deficiency of Interferon-γ Reveals Interferon-γ-Independent Manifestations of Murine Hemophagocytic Lymphohistiocytosis.
    Burn TN; Weaver L; Rood JE; Chu N; Bodansky A; Kreiger PA; Behrens EM
    Arthritis Rheumatol; 2020 Feb; 72(2):335-347. PubMed ID: 31400073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-γ mediates anemia but is dispensable for fulminant toll-like receptor 9-induced macrophage activation syndrome and hemophagocytosis in mice.
    Canna SW; Wrobel J; Chu N; Kreiger PA; Paessler M; Behrens EM
    Arthritis Rheum; 2013 Jul; 65(7):1764-75. PubMed ID: 23553372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice.
    Rood JE; Rao S; Paessler M; Kreiger PA; Chu N; Stelekati E; Wherry EJ; Behrens EM
    Blood; 2016 Jan; 127(4):426-35. PubMed ID: 26518437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Ailal F; Bousfiha A; Deswarte C; Oleaga-Quintas C; Casanova JL; Bustamante J; Liston A
    J Allergy Clin Immunol; 2019 Jun; 143(6):2215-2226.e7. PubMed ID: 30578871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.
    Behrens EM; Canna SW; Slade K; Rao S; Kreiger PA; Paessler M; Kambayashi T; Koretzky GA
    J Clin Invest; 2011 Jun; 121(6):2264-77. PubMed ID: 21576823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and transcriptional impacts of Janus kinase and/or IFN-gamma inhibition in a mouse model of primary hemophagocytic lymphohistiocytosis.
    Albeituni S; Oak N; Tillman HS; Stroh A; Keenan C; Bloom M; Nichols KE
    Front Immunol; 2023; 14():1137037. PubMed ID: 37228616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis.
    Humblet-Baron S; Franckaert D; Dooley J; Bornschein S; Cauwe B; Schönefeldt S; Bossuyt X; Matthys P; Baron F; Wouters C; Liston A
    J Allergy Clin Immunol; 2016 Jul; 138(1):200-209.e8. PubMed ID: 26947179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-18 and cytotoxic impairment are independent and synergistic causes of murine virus-induced hyperinflammation.
    Tsoukas P; Rapp E; Van Der Kraak L; Weiss ES; Dang V; Schneider C; Klein E; Picarsic J; Salcedo R; Stewart CA; Canna SW
    Blood; 2020 Nov; 136(19):2162-2174. PubMed ID: 32589707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.
    Put K; Brisse E; Avau A; Imbrechts M; Mitera T; Janssens R; Proost P; Fallarino F; Wouters CH; Matthys P
    PLoS One; 2016; 11(2):e0150075. PubMed ID: 26914138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
    Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
    J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse Cytomegalovirus Infection in BALB/c Mice Resembles Virus-Associated Secondary Hemophagocytic Lymphohistiocytosis and Shows a Pathogenesis Distinct from Primary Hemophagocytic Lymphohistiocytosis.
    Brisse E; Imbrechts M; Put K; Avau A; Mitera T; Berghmans N; Rutgeerts O; Waer M; Ninivaggi M; Kelchtermans H; Boon L; Snoeck R; Wouters CH; Andrei G; Matthys P
    J Immunol; 2016 Apr; 196(7):3124-34. PubMed ID: 26903481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis.
    Brossard P; Laveille C
    Rheumatol Ther; 2024 Jun; 11(3):869-880. PubMed ID: 38662147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis.
    Das R; Guan P; Sprague L; Verbist K; Tedrick P; An QA; Cheng C; Kurachi M; Levine R; Wherry EJ; Canna SW; Behrens EM; Nichols KE
    Blood; 2016 Mar; 127(13):1666-75. PubMed ID: 26825707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.
    Karakike E; Giamarellos-Bourboulis EJ
    Front Immunol; 2019; 10():55. PubMed ID: 30766533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis.
    Huang R; Hayashi Y; Yan X; Bu J; Wang J; Zhang Y; Zhou Y; Tang Y; Wu L; Xu Z; Liu X; Wang Q; Zhou J; Xiao Z; Bridges JP; Marsh RA; Zhang K; Jordan MB; Li Y; Huang G
    Haematologica; 2017 Nov; 102(11):1956-1968. PubMed ID: 28860338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.
    Jordan MB; Hildeman D; Kappler J; Marrack P
    Blood; 2004 Aug; 104(3):735-43. PubMed ID: 15069016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary HLH susceptibility factors converge on CD8 T-cell hyperactivation.
    Landy E; Varghese J; Dang V; Szymczak-Workman A; Kane LP; Canna SW
    Blood Adv; 2023 Nov; 7(22):6949-6963. PubMed ID: 37738167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease.
    Kögl T; Müller J; Jessen B; Schmitt-Graeff A; Janka G; Ehl S; zur Stadt U; Aichele P
    Blood; 2013 Jan; 121(4):604-13. PubMed ID: 23190531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetics of macrophage activation syndrome.
    Schulert GS; Cron RQ
    Genes Immun; 2020 May; 21(3):169-181. PubMed ID: 32291394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Interferon-γ-Mediated Immunopathology Potentiated by Toll-Like Receptor 9 Activation in a Murine Model of Macrophage Activation Syndrome.
    Weaver LK; Chu N; Behrens EM
    Arthritis Rheumatol; 2019 Jan; 71(1):161-168. PubMed ID: 30073799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.